ALNY - Alnylam Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 58.35B
Enterprise Value 36.64B
Trailing P/E N/A
Forward P/E 1-11.19
PEG Ratio (5 yr expected) 1-0.25
Price/Sales (ttm)78.13
Price/Book (mrq)5.14
Enterprise Value/Revenue 362.13
Enterprise Value/EBITDA 6-11.06

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2017
Most Recent Quarter (mrq)Jun 30, 2018


Profit Margin 0.00%
Operating Margin (ttm)-573.70%

Management Effectiveness

Return on Assets (ttm)-23.76%
Return on Equity (ttm)-41.54%

Income Statement

Revenue (ttm)106.83M
Revenue Per Share (ttm)1.10
Quarterly Revenue Growth (yoy)87.70%
Gross Profit (ttm)89.91M
EBITDA -600.14M
Net Income Avi to Common (ttm)-569.94M
Diluted EPS (ttm)-5.87
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)1.45B
Total Cash Per Share (mrq)14.38
Total Debt (mrq)30M
Total Debt/Equity (mrq)1.85
Current Ratio (mrq)13.22
Book Value Per Share (mrq)16.12

Cash Flow Statement

Operating Cash Flow (ttm)-459.76M
Levered Free Cash Flow (ttm)-375.26M

Trading Information

Stock Price History

Beta (3Y Monthly) 3.25
52-Week Change 3-31.94%
S&P500 52-Week Change 37.40%
52 Week High 3153.99
52 Week Low 378.85
50-Day Moving Average 396.16
200-Day Moving Average 398.50

Share Statistics

Avg Vol (3 month) 3926.99k
Avg Vol (10 day) 3784.94k
Shares Outstanding 5100.67M
Float 89.24M
% Held by Insiders 111.42%
% Held by Institutions 191.61%
Shares Short (Sep 28, 2018) 46.02M
Short Ratio (Sep 28, 2018) 46.51
Short % of Float (Sep 28, 2018) 412.70%
Short % of Shares Outstanding (Sep 28, 2018) 45.98%
Shares Short (prior month Aug 31, 2018) 45.98M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A